The weekly litigation news digest is live. Subscribe now

IP Verse

Tablets Comprising Eltrombopag Olamine - EP4218732

The patent EP4218732 was granted to Novartis on Mar 26, 2025. The application was filed on Aug 1, 2007 under application number EP23166852A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4218732

NOVARTIS
Application Number
EP23166852A
Filing Date
Aug 1, 2007
Status
Granted And Under Opposition
Feb 21, 2025
Publication Date
Mar 26, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ELKINGTON AND FIFESep 9, 2025ELKINGTON AND FIFEADMISSIBLE
STADA ARZNEIMITTELAug 5, 2025MAIWALD -

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2001US16863
DESCRIPTIONWO2003US16255
DESCRIPTIONWO2004US13468
DESCRIPTIONUS2004019190
DESCRIPTIONUS2006178518
DESCRIPTIONUS2007105824
DESCRIPTIONUS7160870
DESCRIPTIONWO0189457
DESCRIPTIONWO03098002
DESCRIPTIONWO2004096154
OPPOSITIONWO03098992
OTHERUS2006178518
OTHERWO2008136843
SEARCHUS2001044474
SEARCHUS2006178518

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents